Esophageal cancer treatment cost in Austria typically includes staging diagnostics like PET-CT scans, which run $1,500 to $2,800, and major surgeries like an esophagectomy, which ranges from $30,000 to $55,000. Total expenses depend on the cancer stage and whether you choose a public university hospital or a private clinic in Vienna. Patients can save approximately 20-30% compared to private care in the United States. Top treatment centers are primarily located in Vienna.
Typical Esophageal Cancer Treatment Costs in Austria
Bookimed Expert Insight: Patients seeking personalized protocols should prioritize private centers like Wiener Privatklinik. Professor Christoph Zielinski provides individualized therapies backed by over 600 scientific publications. For complex cases, large facilities like Vienna General Hospital (AKH) offer extensive multidisciplinary resources. Döbling Private Hospital is ideal for those prioritizing safety, as it strictly implements JCI-International Patient Safety Goals.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Radiation therapy for esophageal carcinoma | from $7,000 | from $20,000 | from $15,000 |
| Esophagectomy | from $23,400 | from $30,000 | from $30,000 |
| Chemotherapy for esophageal carcinoma | from $5,000 | from $12,000 | from $3,500 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Prof. Christoph Zielinski is a globally recognized leader in medical oncology, with over 44 years of experience of experience and pioneering work in cancer immunotherapy.
Prof. Wolfgang Köstler is a leading expert in targeted cancer therapies, with over two decades of experience in medical oncology.
Dr. Sebastian F. Schoppmann is an expert in general and visceral surgery. He has focused on upper gastrointestinal (GI) surgery since 2007. He leads the Gastroesophageal Tumor Unit (CCC-GET) at the Comprehensive Cancer Center Vienna. He is also an Associate Professor of Surgery at the Medical University of Vienna.
Dr. Schoppmann has published over 240 peer-reviewed articles. He serves as a consulting or associate editor for several leading surgical and oncology journals. He is the General Secretary of the Austrian Society of Surgical Oncology. He has also held important leadership roles in surgical oncology organizations. His work has helped advance upper-GI cancer surgery.
Dr. Arnulf Ferlitsch is a specialist in internal medicine, gastroenterology, and hepatology. He completed his medical studies in Vienna in 1998. He continued his training at top institutions, including UCLA and the University of Pennsylvania. From 2000 to 2010, he focused on internal medicine, gastroenterology, hepatology, and intensive care.
Dr. Ferlitsch has received several research awards, such as the UEGW Best Abstract Award (2003, 2005, 2008, 2009, 2010, 2012), the Ferring Prize, and the Skoda Prize. He founded the hepatic hemodynamics laboratory and the liver cirrhosis outpatient clinic at the Medical University of Vienna. Since 2018, he has led the Department of Internal Medicine I at the Hospital of the Barmherzigen Brüder in Vienna.